Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Apr 15, 2024; 16(4): 1596-1612
Published online Apr 15, 2024. doi: 10.4251/wjgo.v16.i4.1596
Published online Apr 15, 2024. doi: 10.4251/wjgo.v16.i4.1596
Figure 1 Study selection process for studies from 1st January 1946 to 17th December 2022.
HCC: Hepatocellular carcinoma; HBV: Hepatitis B virus; G3: Genotype 3.
Figure 2 Meta-analysis with hazard ratios of all included studies on risk factors for hepatocellular carcinoma associated with Hepatitis C Genotype 3.
SOF: Sofosbuvir; DAC: Daclatasvir; RBV: Ribavirin; AFP: Alpha fetoprotein; ALP: Alkaline phosphatase; HCV: Hepatitis C virus.
Figure 3 Funnel plot of all included studies.
Figure 4 Forest plot.
A: Forest plot of studies studying age as a risk factor for hepatocellular carcinoma associated with hepatitis C genotype 3 (HCV-G3); B: Forest plot of studies studying male sex as a risk factor for hepatocellular carcinoma associated with HCV-G3; C: Forest plot of studies studying cirrhosis as a risk factor for hepatocellular carcinoma associated with HCV-G3.
- Citation: Farooq HZ, James M, Abbott J, Oyibo P, Divall P, Choudhry N, Foster GR. Risk factors for hepatocellular carcinoma associated with hepatitis C genotype 3 infection: A systematic review. World J Gastrointest Oncol 2024; 16(4): 1596-1612
- URL: https://www.wjgnet.com/1948-5204/full/v16/i4/1596.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i4.1596